Evidence of differing genotypic effects of PPARalpha in women and men.
Khan
Q H
QH
Pontefract
D E
DE
Iyengar
S
S
Ye
S
S
D000368:Aged; D019943:Amino Acid Substitution; D001161:Arteriosclerosis / Q000097:blood / Q000235:genetics / Q000473:pathology; D015992:Body Mass Index; D015331:Cohort Studies; D003324:Coronary Artery Disease / Q000097:blood / Q000235:genetics* / Q000473:pathology; D003920:Diabetes Mellitus / Q000097:blood / Q000235:genetics / Q000473:pathology; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000235:genetics / Q000473:pathology; D007438:Introns / Q000235:genetics; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000235:genetics / Q000473:pathology; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics*; D012307:Risk Factors; D012737:Sex Factors; D014157:Transcription Factors / Q000235:genetics*; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D014280:Triglycerides